March 9, 2021
- CA US
Compliance4All
Phone:8004479407
Overview:
This session will provide insights on moving from the traditional regulatory strategies for mature technologies to the new regulatory strategies for novel uses of AI and ML while engaging FDA and/or Notified Bodies in the effort. The IMDRF, US and EU perspectives on what s next for AI and ML as SaMD will be explored.
Why you should Attend: This session will engage professionals looking to understand the regulatory challenges of software as a medical device (SaMD) with special focus on AI/Machine Learning (ML).
Areas Covered in the Session:
Describe actual and future AI applications that are changing patient treatment and healthcare delivery through the exploration of real-world examples (across different diagnostic/therapeutic and technology areas)
Bacteriophage Market Analysis: To Reach Around US$ 567.9 Mn In 2027
January 26, 2021 | by admin |
The global bacteriophage market was valued at US$ 567.9 Mn in 2017 expanding at a CAGR of 3.9% from 2018 to 2026.
Market Insights
Recently, bacteriophages or phages have been recognized as an efficient tool in modern biotechnology through a multitude of researches promoting the potential use of bacteriophages across a number of applications. Researchers have also proposed bacteriophages as a viable alternative to antibiotics for a number of antibiotic-resistant bacterial strains. They can also be used as biocontrol agents in the oil and agriculture industries.
Bacteriophages have a unique application in the petroleum industry, as bacterial fouling often leads to serious damage to gas pipelines, devaluing products and therefore increasing capital costs. In addition, bacteriophages may also be used as vaccine vehicles, for the detection of pathogenic bacterial str